Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine.
Year: 2023
Type: article
Study design: Case Report
Source: PubMed
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4377011536
